A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

Mounjaro was launched in India earlier this year, while many leading multinational pharma companies are in the race to introduce Ozempic in the domestic market.

For people with Type 1 diabetes, which often strikes in adolescence, staying healthy can be exhausting. A treatment that can delay the disease’s onset offers some hope .

GLP-1 drugs are not currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 1 diabetes — and they may never be.

FDA Approves Fiasp for Patients with Type 1, Type 2 Diabetes Ozempic is available as 0.5mg and 1mg strength injections in single-patient-use pens that deliver 0.25mg, 0.5mg, or 1mg per injection.

Type 2 diabetes patients on GLP-1 treatments, such as Ozempic, have a lower risk of 10 obesity-related cancers compared to those on insulin and other drugs, according to a new study.

For more than 20 years, Betsy Chadwell carried her insulin pens everywhere. Day in and day out, she carefully calibrated the doses needed to keep her Type 2 diabetes in check. “Every meal, and ...

Ozempic and Rybelsus both treat diabetes and cause weight loss, ... Novo Nordisk announced that it would seek FDA approval for larger doses of oral semaglutide for the treatment of type 2 diabetes.